News
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
20h
Zacks.com on MSNAmgen Looks to Take Share of Booming Obesity Space: Will It Succeed?Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
19h
Zacks Investment Research on MSNNVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results